# A First-in-Human Study to Assess Single and Multiple Doses of NXC736 in Healthy Participants

> **NCT05079425** · PHASE1 · COMPLETED · sponsor: **NEXTGEN Bioscience** · enrollment: 72 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** NXC736
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05079425
- **Lead sponsor:** NEXTGEN Bioscience
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05079425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05079425, "A First-in-Human Study to Assess Single and Multiple Doses of NXC736 in Healthy Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05079425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*